Enlight Biosciences LLC

Enlight Biosciences LLC

Enlight Biosciences LLC

Overview
Date Founded

2005

Headquarters

500 Boylston Street,Suite 1600,Boston, MA 02116-3891

Type of Company

Private

Industries

Pharmaceuticals
Holding Companies
Retail: Drug Stores

Company Description

Enlight Biosciences LLC develops research tools for drug discovery and development. It offers patient-centric platforms that may impact all aspects of the connected health ecosystem from patient engagement and experience, to patient-focused research and development. The company was founded by Raju S. Kucherlapati, David Steinberg, Rakesh Kumar Jain, H. Robert Horbitz, and Sanjiv Sam Gambhir in July 2008 and is headquartered in Boston, MA.

Executives & Employees

Senior Director-Technology & Business Development

Director

Board of Directors

Co-Founder at PureTech Health PLC

Director-Tumor Biology Steele Lab at The Massachusetts General Hospital

Venture Partner at Longwood Fund Management LLC

Associate at Puretech Health LLC

Partner at SV Health Investors LLP

Paths to Enlight Biosciences LLC
Potential Connections via
Relationship Science
You
Enlight Biosciences LLC
Advisors & Consultants
Advisor

Former MD & Chief Information Officer at CareGroup, Inc.

Advisor

Managing Partner at Jazz Venture Partners LLC

Advisor

Co-Founder at Accountable Care Transactions, Inc.

Investments
Details Hidden

Knode, Inc. develops and delivers web-based life science solutions for accessing experts and their content. It offers solutions for project team formation, post-merger integration, collaborations, business development, and decision-making applications. The firm provides services to pharmaceutical companies, academic institutions and researchers. The company was founded in 2011 and is headquartered in Boston, MA.

Investors
Details Hidden

AstraZeneca UK Ltd. manufactures pharmaceutical products. Its products are used to treat cardiovascular diseases, diabetes, and gastrointestinal infections. The company was founded on November 26, 1998 and is headquartered in London, the United Kingdom.

Details Hidden

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Details Hidden

NVF is an active venture capital investor focused exclusively on life sciences. They contribute financially as well as by taking Board positions. They seek initial early-stage investments to develop, nurture and support innovative therapeutics. They balance these investments with those in medical devices, diagnostics and drug delivery systems, areas critical to patient care and the healthcare industry.NVF's early-stage investments are also complemented by their follow-on investment rounds leading to more advanced unlisted firms within the life sciences sector. Investment criteria include looking for unmet needs, clinical impact and new proprietary science. Investments are made in North America, Europe, and Switzerland and in Asia/Pacific.The Novartis Option Fund is designed to provide an alternative financing vehicle. The investment focus is on financing during the earliest stages of start-up firms that are developing novel technologies and programs which may ultimately contribute to Novartis' own research projects. The fund's strategy is high risk / high return.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Enlight Biosciences LLC. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Enlight Biosciences LLC's profile does not indicate a business or promotional relationship of any kind between RelSci and Enlight Biosciences LLC.